Table of Contents Author Guidelines Submit a Manuscript
International Journal of Hepatology
Volume 2016 (2016), Article ID 5160754, 8 pages
http://dx.doi.org/10.1155/2016/5160754
Research Article

Cardiovascular Autonomic Dysfunction in Patients of Nonalcoholic Fatty Liver Disease

1Department of Internal Medicine, All India Institute of Medical Sciences, New Delhi 110029, India
2Department of Physiology, All India Institute of Medical Sciences, New Delhi 110029, India
3Department of Radiodiagnosis, All India Institute of Medical Sciences, New Delhi 110029, India
4Department of Cardiac Biochemistry, All India Institute of Medical Sciences, New Delhi 110029, India
5Department of Biostatistics, All India Institute of Medical Sciences, New Delhi 110029, India

Received 23 August 2016; Accepted 14 November 2016

Academic Editor: Daisuke Morioka

Copyright © 2016 Mavidi Sunil Kumar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. C. Farrell, V. W.-S. Wong, and S. Chitturi, “NAFLD in Asia—as common and important as in the West,” Nature Reviews Gastroenterology and Hepatology, vol. 10, no. 5, pp. 307–318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. S. A. Harrison and C. P. Day, “Benefits of lifestyle modification in NAFLD,” Gut, vol. 56, no. 12, pp. 1760–1790, 2007. View at Publisher · View at Google Scholar
  3. M. Stepanova and Z. M. Younossi, “Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the us population,” Clinical Gastroenterology and Hepatology, vol. 10, no. 6, pp. 646–650, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Hamaguchi, T. Kojima, N. Takeda et al., “Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease,” World Journal of Gastroenterology, vol. 13, no. 10, pp. 1579–1584, 2007. View at Publisher · View at Google Scholar
  5. H. Lu, L. Zeng, B. Liang, X. Shu, and D. Xie, “High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease,” Archives of Medical Research, vol. 40, no. 7, pp. 571–575, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Cailotto, C. Van Heijningen, J. Van Der Vliet et al., “Daily rhythms in metabolic liver enzymes and plasma glucose require a balance in the autonomic output to the liver,” Endocrinology, vol. 149, no. 4, pp. 1914–1925, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Sabath, A. Báez-Ruiz, and R. M. Buijs, “Non-alcoholic fatty liver disease as a consequence of autonomic imbalance and circadian desynchronization,” Obesity Reviews, vol. 16, no. 10, pp. 871–882, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. J. L. Newton, J. Pairman, K. Wilton, D. E. J. Jones, and C. Day, “Fatigue and autonomic dysfunction in non-alcoholic fatty liver disease,” Clinical Autonomic Research, vol. 19, no. 6, pp. 319–326, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Sun, D. Zhang, J. Sun et al., “Association between non-alcoholic fatty liver disease and autonomic dysfunction in a Chinese population,” QJM, vol. 108, no. 8, pp. 617–624, 2015. View at Publisher · View at Google Scholar
  10. E. T. Oni, A. S. Agatston, M. J. Blaha et al., “A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?” Atherosclerosis, vol. 230, no. 2, pp. 258–267, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. M. L. Thakur, S. Sharma, A. Kumar et al., “Nonalcoholic fatty liver disease is associated with subclinical atherosclerosis independent of obesity and metabolic syndrome in Asian Indians,” Atherosclerosis, vol. 223, no. 2, pp. 507–511, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Kaur, D. Chandran, C. Lal et al., “Renal transplantation normalizes baroreflex sensitivity through improvement in central arterial stiffness,” Nephrology Dialysis Transplantation, vol. 28, no. 10, pp. 2645–2655, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. E. R. Carthy, “Autonomic dysfunction in essential hypertension: a systematic review,” Annals of Medicine and Surgery, vol. 3, no. 1, pp. 2–7, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. Y.-C. Liu, C.-S. Hung, Y.-W. Wu et al., “Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability,” PLoS ONE, vol. 8, no. 4, article e61803, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. G. Jakovljevic, K. Hallsworth, P. Zalewski et al., “Resistance exercise improves autonomic regulation at rest and haemodynamic response to exercise in non-alcoholic fatty liver disease,” Clinical Science, vol. 125, no. 3, pp. 143–149, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Kuehl and M. J. Stevens, “Cardiovascular autonomic neuropathies as complications of diabetes mellitus,” Nature Reviews Endocrinology, vol. 8, no. 7, pp. 405–416, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. J. M. Hazlehurst, C. Woods, T. Marjot, J. F. Cobbold, and J. W. Tomlinson, “Non-alcoholic fatty liver disease and diabetes,” Metabolism, vol. 65, no. 8, pp. 1096–1108, 2016. View at Publisher · View at Google Scholar
  18. M. R. Souza, M. D. Diniz, J. E. Medeiros-Filho, and M. S. Araújo, “Metabolic syndrome and risk factors for non-alcoholic fatty liver disease,” Arquivos de Gastroenterologia, vol. 49, no. 1, pp. 89–96, 2012. View at Publisher · View at Google Scholar
  19. M. Gaggini, M. Morelli, E. Buzzigoli, R. A. DeFronzo, E. Bugianesi, and A. Gastaldelli, “Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease,” Nutrients, vol. 5, no. 5, pp. 1544–1560, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. C. D. Byrne and G. Targher, “NAFLD: a multisystem disease,” Journal of Hepatology, vol. 62, no. 1, pp. S47–S64, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Nigam, S. P. Bhatt, A. Misra, M. Vaidya, J. Dasgupta, and D. S. Chadha, “Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India,” PLoS ONE, vol. 8, no. 1, Article ID e49286, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. R. Ajmal, M. Yaccha, M. A. Malik et al., “Prevalence of nonalcoholic fatty liver disease (NAFLD) in patients of cardiovascular diseases and its association with hs-CRP and TNF-α,” Indian Heart Journal, vol. 66, no. 6, pp. 574–579, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. Liu, M. Dai, Y. Bi et al., “Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): A Population-Based Study in China,” Journal of Epidemiology, vol. 23, no. 2, pp. 115–121, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Oikawa, M. Umetsu, T. Toyota, and Y. Goto, “Quantitative evaluation of diabetic autonomic neuropathy by using heart rate variations: relationship between cardiac parasympathetic or sympathetic damage and clinical conditions,” Tohoku Journal of Experimental Medicine, vol. 148, no. 2, pp. 125–133, 1986. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Verrotti, G. Loiacono, A. Mohn, and F. Chiarelli, “New insights in diabetic autonomic neuropathy in children and adolescents,” European Journal of Endocrinology, vol. 161, no. 6, pp. 811–818, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Ueda, N. Kuroda, M. Ogura et al., “Importance of serum cholesterol level in development of diabetic autonomic neuropathy,” Diabetes Research and Clinical Practice, vol. 21, no. 2-3, pp. 123–126, 1993. View at Publisher · View at Google Scholar · View at Scopus
  27. N. M. Pimenta, H. Santa-Clara, H. Cortez-Pinto et al., “Body composition and body fat distribution are related to cardiac autonomic control in non-alcoholic fatty liver disease patients,” European Journal of Clinical Nutrition, vol. 68, no. 2, pp. 241–246, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Targher, I. Pichiri, G. Zoppini, M. Trombetta, and E. Bonora, “Increased prevalence of cardiovascular disease in type 1 diabetic patients with non-alcoholic fatty liver disease,” Journal of Endocrinological Investigation, vol. 35, no. 5, pp. 535–540, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. L. H. Yan, B. Mu, Y. Guan et al., “Assessment of the relationship between non-alcoholic fatty liver disease and diabetic complications,” Journal of Diabetes Investigation, vol. 7, no. 6, pp. 889–894, 2016. View at Publisher · View at Google Scholar
  30. I. S. Idilman, D. Akata, T. Hazirolan, B. Doganay Erdogan, K. Aytemir, and M. Karcaaltincaba, “Nonalcoholic fatty liver disease is associated with significant coronary artery disease in type 2 diabetic patients: A Computed Tomography Angiography Study,” Journal of Diabetes, vol. 7, no. 2, pp. 279–286, 2015. View at Publisher · View at Google Scholar · View at Scopus